Procoagulant properties of intravenous staphylokinase versus tissue-type plasminogen activator.

Okada, K

Procoagulant properties of intravenous staphylokinase versus tissue-type plasminogen activator. [electronic resource] - Thrombosis and haemostasis Dec 1996 - 857-9 p. digital

Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial

0340-6245


Fibrinolytic Agents--administration & dosage
Humans
Metalloendopeptidases--administration & dosage
Myocardial Infarction--drug therapy
Recombinant Proteins--administration & dosage
Tissue Plasminogen Activator--administration & dosage
Treatment Outcome